How is a biosimilar approved? Comparative effectiveness study for the reason that the medication was initial approved required, not for other indications Jonathan Kay shows ex of ETN-ykro vs reference ETN in RA Non-inferior in immunogenicity, safety, efficacy @RheumNow #RNL2023 https://t.co/OOHie9Qr5t